NasdaqGS:SNDXBiotechs
Assessing Syndax Pharmaceuticals (SNDX) Valuation After Recent Share Price Momentum
Why Syndax Pharmaceuticals (SNDX) Is Drawing Investor Attention Now
Syndax Pharmaceuticals (SNDX) has been catching investor interest after recent trading, with the stock last closing at US$24.23 and recent returns over the month and past 3 months standing out in the biotech space.
See our latest analysis for Syndax Pharmaceuticals.
For context, Syndax Pharmaceuticals has a 30 day share price return of 23.06% and a year to date share price return of 13.76%, while the 1 year total shareholder...